Lindsay Sylvester, Author at EverGlade Consulting

Lindsay Sylvester

Everglad avatar
Protein sequencing machine

DARPA PROSE Program: Enabling the Next Leap in Protein Sequencing Technology

Leave a Comment / DARPA, Emerging Technologies / By

Program Announcement PROtein SEquencing (PROSE) Microsystems Technology Office The Defense Advanced Research Projects Agency (DARPA), through its Microsystems Technology Office (MTO), has issued a new Program Announcement (DARPA-PA-25-06) for its PROtein SEquencing (PROSE) initiative. This bold program seeks to overcome longstanding challenges in protein sequencing by investing in novel microsystems and signal processing architectures. PROSE […]

DARPA PROSE Program: Enabling the Next Leap in Protein Sequencing Technology Read More »

Digital illustration of the lymphatic system in the human body from chest up.

MCDC Solicitation RPP 25-05 – OPNA Prophylaxis Technology Development Opportunity

Leave a Comment / JPEO, Life Sciences / By

The U.S. Army Contracting Command – New Jersey (ACC-NJ), in support of the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a new Request for Prototype Proposals (RPP-25-05) through the Medical CBRN Defense Consortium (MCDC). Administered by Advanced Technology International (ATI), this solicitation seeks novel approaches for enhancing the

MCDC Solicitation RPP 25-05 – OPNA Prophylaxis Technology Development Opportunity Read More »

Viral pathogen coronavirus

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats

Leave a Comment / All Posts, JPEO, Life Sciences / By

The U.S. Department of Defense (DoD), through the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND), has released a Request for Prototype Proposals (RPP-25-06) under the Medical CBRN Defense Consortium (MCDC) under OTA W15QKN-16-9-1002. This new initiative, Operationalizing Novel Technologies for Advanced Rapid Generation of Effective Medical Countermeasures (ONTARGET), is looking

DTRA ONTARGET: Platforms to Accelerate Novel Medical Countermeasure Development for CBRN Threats Read More »

3d rendered image of highly pathogenic avian influenza

MCDC Announces “Increased Micro Sampling to Monitor Immunological Response” RPP

Leave a Comment / All Posts, DTRA, Life Sciences / By

The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA), has issued a new Request for Prototype Proposals (RPP) through the Medical CBRN Defense Consortium (MCDC). “Increased Micro Sampling to Monitor Immunological Response” (IMMIR) seeks to improve our ability to monitor immune responses to vaccination, which is critical for accelerating vaccine

MCDC Announces “Increased Micro Sampling to Monitor Immunological Response” RPP Read More »

digital rendering of antigens

MCDC Releases “Defined Rapid Antigen Identification and Immunogenic Characterization” RPP

Leave a Comment / All Posts, DTRA, Life Sciences / By

The U.S. Department of Defense (DoD), through the Joint Science and Technology Office (JSTO) Defense Threat Reduction Agency (DTRA), has released a new Request for Prototype Proposals (RPP-25-07) under the Medical CBRN Defense Consortium (MCDC). This Request for Project Proposals, titled “Defined Rapid Antigen Identification and Immunogenic Characterization” (DRAIIC), aims to increase protection against infectious

MCDC Releases “Defined Rapid Antigen Identification and Immunogenic Characterization” RPP Read More »

Scroll to Top